An individual who meets any of the following criteria will be excluded from participation in this study 1. Self-reported history of COVID-19 disease or history of laboratory-confirmed COVID-19 (RT-PCR positive to SARS-CoV-2). 2.Prior receipt of a COVID-19 vaccine. 3. Prior or planned administration of a non-study vaccine within 30 days before the first dose of study vaccine or 30 days after the second vaccination, respectively. 4. History of allergic reactions or anaphylaxis to any previous immunizations. 5. History of allergies to eggs, chicken, or any components of the study vaccine. 6. Fever (More than 38.0 celsius) within the past 24 hours. 7. Administration of immunoglobulins and,or any blood products within the three months preceding the planned administration of the study vaccine. 8. History of bleeding disorder (example factor deficiency, coagulopathy, or platelet disorder), or prior history of significant bleeding or bruising following intramuscular (IM) injections or venipuncture.

An individual who meets any of the following criteria will be excluded from participation in this study 1. Self-reported history of COVID-19 disease or history of laboratory-confirmed COVID-19 (RT-PCR positive to SARS-CoV-2). 2.Prior receipt of a COVID-19 vaccine. 3. Prior or planned administration of a non-study vaccine within 30 days before the first dose of study vaccine or 30 days after the second vaccination, respectively. 4. History of allergic reactions or anaphylaxis to any previous immunizations. 5. History of allergies to eggs, chicken, or any components of the study vaccine. 6. Fever (More than 38.0 celsius) within the past 24 hours. 7. Administration of immunoglobulins and,or any blood products within the three months preceding the planned administration of the study vaccine. 8. History of bleeding disorder (example factor deficiency, coagulopathy, or platelet disorder), or prior history of significant bleeding or bruising following intramuscular (IM) injections or venipuncture.